CIK 0001022899 · Non-accelerated filer<br>Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061390025
- Phone
- (212) 994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $23,756
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-21 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +307,497 | 307,497 | ||
| 2019-03-20 | Arrow Alexander K. Chief Financial Officer | Grant or award · PTIX Common stock Options | +41,667 | 41,667 | ||
| 2017-10-16 | Corvese Brian Director | Grant or award · Non-Qualified Stock Options (Right to Buy) | +95,000 | 95,000 | ||
| 2017-10-16 | Arrow Alexander K. Chief Financial Officer | Grant or award · Non-Qualified Stock Options (Right to Buy) | +75,000 | 75,000 | ||
| 2017-10-16 | ARMEN GARO H Executive Chairman | Grant or award · Non-Qualified Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2017-10-16 | Stein Robert Benjamin Director | Grant or award · Non-Qualified Stock Options (Right to Buy() | +200,000 | 200,000 | ||
| 2017-10-16 | Silverman Joshua Director | Grant or award · Non-Qualified Stock Options (Right to Buy) | +45,000 | 45,000 | ||
| 2017-10-16 | Barrage Khalil Director | Grant or award · Non-Qualified Stock Options (Right to Buy) | +45,000 | 45,000 | ||
| 2016-08-08 | Barrage Khalil Director | Grant or award | +150,000 | $1.25 | $188K | 245,000 |
| 2016-06-17 | ARMEN GARO H See Remarks | Purchase | +60,211 | $1.25 | $75K | 4,299,379 |
| 2016-06-17 | Ekizian Gregory Director | Grant or award | +45,000 | $1.25 | $56K | 645,000 |
| 2016-06-17 | Arrow Alexander K. Chief Financial Officer | Grant or award | +140,000 | $1.25 | $175K | 358,260 |
| 2016-06-17 | ARMEN GARO H See Remarks | Grant or award | +500,000 | $1.25 | $625K | 4,239,168 |
| 2016-06-17 | Silverman Joshua Director | Grant or award | +45,000 | $1.25 | $56K | 45,000 |
| 2016-06-17 | Barrage Khalil Director | Grant or award | +45,000 | $1.25 | $56K | 245,000 |
| 2016-06-17 | Stein Robert Benjamin Director | Grant or award | +40,000 | $1.25 | $50K | 240,000 |
| 2016-04-15 | Arrow Alexander K. Chief Financial Officer | Purchase · Series B Preferred Stock | +40,000 | $1.25 | $50K | 100,000 |
| 2016-04-15 | Arrow Alexander K. Chief Financial Officer | Purchase · Series B Preferred Stock | +18,260 | $1.25 | $23K | 118,260 |
| 2011-05-31 | BRILLIANT DIGITAL ENTERTAINMENT INC 10% owner | Purchase · Secured Convertible Promissory Note (right to buy) | +758,621 | 758,621 | ||
| 2011-05-31 | BRILLIANT DIGITAL ENTERTAINMENT INC 10% owner | Purchase · Common Stock Warrants (right to buy) | +758,621 | 758,621 |
Page 3 of 10 · 196 trades